<DOC>
	<DOCNO>NCT01825421</DOCNO>
	<brief_summary>Unnecessary prolong antibiotic therapy newborn baby serious consequence include development necrotizing enterocolitis ( serious , potentially life-threatening gastrointestinal illness premature baby ) , late-onset infection , resistance antibiotic , increase length hospital stay , death . Starting continue antibiotic therapy blood culture-negative infection neonatal intensive care unit ( NICU ) fairly common number patient vary 20 % -90 % infant undergoing sepsis evaluation NICU . While blood culture result gold standard , usually delay 48-72h result know . Hence , initiation continuation antibiotic treatment usually base clinical evaluation blood count criterion possess high specificity sensitivity , may unreliable first hour birth early stage infection . Since investigator find neutrophil CD64 ( type protein find surface type white blood cell detect quickly small amount blood sample ) high accuracy early detection blood culture-proven infection newborn baby , extremely high negative predictive value ( identify baby definitively infection ) , investigator use test decide whether stop continue antibiotic NICU . The investigator hypothesis neutrophil CD64 value safely use discontinue antibiotic newborn suspect infection . The investigator aim utilize sequential measurement CD64 value stop antibiotic early neonate investigate early late-onset infection NICU . This prospective , randomize , control ( RCT ) trial . The study population derive sub-set newborn infant undergone investigation presence infection NICU .</brief_summary>
	<brief_title>A Pilot Randomized Controlled Trial Antibiotic Exposure Neonatal Sepsis Using Neutrophil CD64</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Infants undergo sepsis evaluation NICU They major lifethreatening congenital malformation The attend neonatologist objection infant participate study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Months</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Infant</keyword>
	<keyword>Infection</keyword>
	<keyword>Newborn</keyword>
	<keyword>Antibiotics</keyword>
	<keyword>Neutrophil CD64</keyword>
	<keyword>Blood Culture</keyword>
</DOC>